Evidence Hub

A Rare Case of Giant Cell Hepatitis Superimposed on Sickle Cell Hepatopathy

Sethi S, Xue Y, Ramkissoon R

ACG case reports journal, 2026

Abstract

Giant cell hepatitis (GCH) is a rare histopathologic pattern of liver injury characterized by multinucleated syncytial hepatocytes within inflamed parenchyma and is a pattern most commonly seen in infants rather than adults. We report a case of levofloxacin-induced GCH superimposed on sickle cell hepatopathy in a 20-year-old woman with sickle cell disease. She presented with recurrent transaminitis and severe hyperbilirubinemia shortly after initiation of levofloxacin. Liver biopsy revealed sinusoidal congestion and fibrosis consistent with sickle cell hepatopathy, along with portal inflammation, bile duct injury, and multinucleated hepatocytes diagnostic of GCH. Prednisone therapy was started, which led to marked biochemical and histologic improvement, and subsequent resolution of GCH on repeat biopsy. This case emphasizes the diagnostic utility of liver biopsy in sickle cell disease in medical management.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free